A NEW HIGHLY POTENT PARATHYROID HORMONE ANTAGONIST: [D-TRPl2,TYR34]bPTH-(7–34)NH2

Publisher Website
Google Scholar
Abstract
Based upon N-terminal parathyroid hormone (PTH) analog structure (PTH) analog structure-activity relationship studies, position 12 was found to possess a wide structural latitude and was chosen as a site for single amino acid substitutions. Replacement of the naturally-occurring Gly with D-trp at position 12 in the PTH antagonists [Tyr34]bPTH-(7--34)NH2 and [Nle8,18,Tyr34]bPTH-(7--34)NH2 increased in vitro receptor affinity. The D-Trp12 containing analogs were 12-fold more potent than their unsubstituted counterparts as inhibitors of PTH binding to renal and bone PTH receptors and 13-27-fold more potent as inhibitors of PTH-stimulated renal and bone adenylate cyclase activity. Based upon Scatchard analyses of saturation binding experiments and Schild analyses of adenylate cyclase experiments, [D-Trp12,Tyr34]bPTH-(7--34)NH2 was shown to interact with PTH receptors in a competitive manner. These studies demonstrate, therefore, that D-Trp12 substitution in PTH antagonists improves inhibitory properties in vitro and is compatible with a helical conformation at this position as a new direction for the design of PTH antagonists.